Biotech slump forces Re­silience to wind down six man­u­fac­tur­ing sites, us­ing bank­rupt­cy move

The ven­ture-backed drug man­u­fac­tur­ing com­pa­ny Na­tion­al Re­silience said it will close six un­der­uti­lized sites in a sig­nif­i­cant re­set of its am­bi­tions to grow in­to a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER